@fritzo I tracked all the PSA-type tests; I wanted to know if anything worse was lurking unseen.
> the PSE test became available in September 2023; I never had that.

After going off active surveillance, I chose proton radiation + 6 months of hormone therapy. (If I have recurrence, I have the options of focal therapy (e.g., cryo), brachytherapy, SBRT (because they’re all very targetable), and even possibly even re-radiation. (I was diagnosed in 2012; had 4 transrectal biopsies during the 9 years that I was on active surveillance.)

For me, I had both the OncotypeDx and Prolaris tests.
> the OncotypeDx test was to help with my decision to go onto active surveillance.
> the Prolaris test was to help with my decision to go off of active surveillance.

Which biomarker test to use would depend on what someone starting on this journey was looking for (& what their insurance will pay for). That’s the in-depth discussion between patient and doctor.